Brief Description of the Company
Founded in 1986 in Istanbul, Polifarma Pharmaceuticals is active in IV fluids (serum) production over 30 years. By March 2011, Polifarma carried out its manufacturing activities to Ergene facility. Since 2011 Polifarma invested more than $ 100 million to expand its production lines, technology and capacity. Polifarma’s state of art production facility uses advanced technological equipment and operates in compliance with the norms of current Good Manufacturing Practices (cGMP). Polifarma oers extensive form and volume alternatives in the production of large volume parenterals. While focusing product range by several packaging alternatives in LVP, Polifarma widens the product range with vials, lyophilized powders and prefilled syringes in SVP. By April 2016 Polifarma started manufacturing at its own aseptic line. Currently Polifarma is manufacturing more than 50 products in SVP lines at different therapeutic areas. By the beginning of 2019, Polifarma became the 1st local company started manufacturing parenteral nutrition solutions at 3 chamber bags (Lipid+Aminoacid+Glucose) The company aims to become a global leader in the field of injectibles and is continuously enlarging networks at international markets.

Production Area
70.000 sqm land & 30,000 sqm closed area with aseptic and parenteral lines.

Annual Production Capacity
IV Fluids : 120 Million units
Vials : 40 Million units
Ampoules: 30 Million units
Lyophilised Vials : 6 Million units
Prefilled Syringes (PFS) : 10 Million units
3 chamber bags : 3 Million units

GMP Certificates
Turkey

Other Certificates
ISO 9001, ISO 13485, ISO 14001, OHSAS 18001

Number of Employees
900